Close
ACHEMA MIDDLE EAST 2026

Tag: Europe

Live broadcast of session on biosimilars and EU regulation: still time to join us!

On February 8th, the EDQM will hold a dedicated session jointly organised with the European Medicines Agency on the role of the European Pharmacopoeia...

Johnson Matthey Fine Chemicals launches new online catalyst store

The store has been introduced to provide customers with easy access to research quantities of commercial grade ligands and catalysts, to accelerate development of...

Glaxosmithkline plc- ARIA Study Shows Superior Efficacy of Triumeq for Treatment-naïve women living with HIV

ViiV Healthcare presented 48-week data from the phase IIIb, open-label, international, multi-centre ARIA study which showed superior efficacy for Triumeq compared with atazanavir boosted...

EMA accepts Merck’s MAA for cladribine tablets in multiple sclerosis

Merck, a leading science and technology company announced that the EMA to request the company for marketing approval for its investigational Cladribine Tablets for...

Biogen SB5 accepted for review by European Medicines Agency

The Marketing Authorization Application (MAA) for SB5, an adalimumab biosimilar candidate referencing Humira®1, has been accepted for review by the European Medicines Agency (EMA)....

Popular